Showing results (641-650 of 3,470) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|May 25, 2013
Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitorsBenoit Chauvin, Sylvain Drouot, Aurélie Barrail-Tran, et al.Clinical Pharmacokinetics|May 9, 2013
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazoleSebastian Frechen, Lisa Junge, Teijo I Saari, et al.Clinical Pharmacokinetics|January 25, 2013
Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously)Ryuichi Ogawa, Joan M Stachnik, Hirotoshi EchizenClinical Pharmacokinetics|September 10, 2014
Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous systemAndrea Calcagno, Giovanni Di Perri, Stefano BonoraClinical Pharmacokinetics|September 20, 2014
Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndromeYulan Qi, Donald G Musson, Becky Schweighardt, et al.Clinical Pharmacokinetics|September 25, 2014
Pharmacokinetics of antidepressants in patients with hepatic impairmentMassimo Carlo Mauri, Alessio Fiorentini, Silvia Paletta, et al.Clinical Pharmacokinetics|October 26, 2013
Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antiviralsTony K L Kiang, Kyle J Wilby, Mary H H EnsomClinical Pharmacokinetics|November 28, 2012
Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionateAnn Allen, Philippe J Bareille, Vicki M RousellClinical Pharmacokinetics|November 13, 2013
The basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spotsMassimiliano Donzelli, Adrian Derungs, Maria-Giovanna Serratore, et al.Clinical Pharmacokinetics|December 12, 2013
How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Azrin N Abd Rahman, Susan E Tett, Christine E StaatzPageof 347